Cargando…

Atherogenic Plasma Index or Non-High-Density Lipoproteins as Markers Best Reflecting Age-Related High Concentrations of Small Dense Low-Density Lipoproteins

The study aimed to assess the strength of the relationships between small dense low-density lipoproteins (sdLDL) and other parameters describing metabolic disorders and determine which of the lipid profile parameters can be used as markers of increased sdLDL concentration. The proposed model of sdLD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Płaczkowska, Sylwia, Sołkiewicz, Katarzyna, Bednarz-Misa, Iwona, Kratz, Ewa Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102874/ https://www.ncbi.nlm.nih.gov/pubmed/35563477 http://dx.doi.org/10.3390/ijms23095089

Ejemplares similares

Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
por: Ikezaki, Hiroaki, et al.
Publicado: (2021)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action
por: Nagao, Manabu, et al.
Publicado: (2018)

Consuming High-Fat and Low-Fat Ground Beef Depresses High-Density and Low-Density Lipoprotein Cholesterol Concentrations, and Reduces Small, Dense Low-Density Lipoprotein Particle Abundance
por: Lytle, Jason R., et al.
Publicado: (2023)

Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
por: Fonseca, Liliana, et al.
Publicado: (2020)

Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
por: Tian, Li, et al.
Publicado: (2010)

Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process
por: Kim, Jae-Yong, et al.
Publicado: (2016)

The Role of the Low-Density Lipoprotein/High-Density Lipoprotein Cholesterol Ratio as an Atherogenic Risk Factor in Young Adults with Ischemic Stroke: A Case—Control Study
por: Ciplak, Sibel, et al.
Publicado: (2023)

AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE(−/−) mice
por: Ma, Ang, et al.
Publicado: (2017)

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
por: Syed, Shahan, et al.
Publicado: (2021)

Effects of smoking cessation using varenicline on the serum concentrations of oxidized high-density lipoprotein: Comparison with high-density lipoprotein cholesterol
por: Umeda, Akira, et al.
Publicado: (2022)

High-Density Lipoproteins and the Kidney
por: Strazzella, Arianna, et al.
Publicado: (2021)

High Density Lipoproteins and Diabetes
por: Cochran, Blake J., et al.
Publicado: (2021)

Serum concentrations of small dense low‐density lipoprotein cholesterol and lipoprotein(a) are related to coronary arteriostenosis in Takayasu arteritis
por: Chen, Si, et al.
Publicado: (2021)

Biosynthesis of high density lipoprotein by chicken liver: nature of nascent intracellular high density lipoprotein
por: Banerjee, D, et al.
Publicado: (1983)

Elevation of small, dense low density lipoprotein cholesterol—a possible antecedent of atherogenic lipoprotein phenotype in type 2 diabetes patients in Jos, North-Central Nigeria
por: Inaku, Kenneth O., et al.
Publicado: (2017)

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
por: Lawler, Patrick R., et al.
Publicado: (2017)

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
por: Androulakis, Emmanuel, et al.
Publicado: (2017)

Is Non-High-Density Lipoprotein Cholesterol Evaluation Perfect? From the High-Density Lipoprotein Function Viewpoint
por: Otsuka, Toshiaki
Publicado: (2022)

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety
Publicado: (1995)

The Impact of Lipoprotein Apheresis on Oxidative Stress Biomarkers and High-Density Lipoprotein Subfractions
por: Mickiewicz, Agnieszka, et al.
Publicado: (2020)

Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults
por: Kawamoto, Ryuichi, et al.
Publicado: (2010)

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
por: Ivanova, Ekaterina A., et al.
Publicado: (2017)

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

High Density Lipoprotein and it’s Dysfunction
por: Eren, Esin, et al.
Publicado: (2012)

High-Density Lipoproteins and the Immune System
por: Kaji, Hidesuke
Publicado: (2013)

Presepsis biomarker: high-density lipoprotein
por: Al-Zaidawi, S
Publicado: (2014)

The Role of High Density Lipoproteins in Thrombosis
por: Cuchel, Marina, et al.
Publicado: (2002)

High-Density Lipoproteins Are Bug Scavengers
por: Meilhac, Olivier, et al.
Publicado: (2020)

High-Density Lipoproteins in Kidney Disease
por: Kon, Valentina, et al.
Publicado: (2021)

Quantitative glycoproteomics of high-density lipoproteins
por: Tang, Xinyu, et al.
Publicado: (2022)

Impact of High-Density Lipoproteins on Sepsis
por: De Geest, Bart, et al.
Publicado: (2022)

The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses
por: Moriyama, Kengo
Publicado: (2020)

Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
por: Kim, Hye Jun, et al.
Publicado: (2023)

High-density lipoprotein cholesterol: How High
por: Rajagopal, G., et al.
Publicado: (2012)

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
por: Popa, Calin D., et al.
Publicado: (2012)

Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Further evidence that high-density lipoprotein is a chameleon-like lipoprotein
por: Fogelman, Alan M.
Publicado: (2015)

Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein
por: Itabe, Hiroyuki, et al.
Publicado: (2021)

Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein
por: Juhi, Ayesha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dij7kg4vrmoq21roh0eok8effc